In the market for more than 57 years, the Profarma Group is the most diversified player in the health sector, with business units in the Distribution, Specialties and Retail segments. In 2006, it became the first company in the sector to list its shares on the Novo Mercado segment of BM&FBovespa. With a track record of well integrated acquisitions and a solid reputation, it is currently one of the 200 largest private groups in Brazil.
Profarma Distribuidora de Produtos Farmacêuticos, which is the core business of the company, makes up the Distribution Division. The operation currently has the capacity to serve a geographical area that corresponds to nearly 96% of the consumer market for pharmaceutical products in Brazil.
• Top 2 in Brazil
• 9 Distribution Centers: Bahia, Goiás, Minas Gerais, Paraíba, Paraná, Pernambuco, Rio de Janeiro, Rio Grande do Sul and São Paulo, four of them automated
• More than 10,000 items in the product mix
• 690,000 orders per month
• 37,000 drugstores supplied per month
• 3,800 cities served
• 2,606 employees
The Specialties Division is comprised of Profarma Specialty, a joint venture created from the strategic partnership between Profarma and AmerisourceBergen, a world leader in the specialties segment.
With the know-how of AmerisourceBergen and the expertise of Profarma in the national market, Profarma Specialty is consolidated in the Brazilian market as the only player to offer its clientes integrated solutions: Distribution, Pharmacy of Specialties and Patient Support programs.
Today we have complete structure to follow out commitment to continuously improve health in Brazil and the world, helping people access the medicines they need every day.
• Nationwide service
• More than 1000 products in stock
• Sales teams with more than 100 specialized sales consultants
• Complete portfolio in the main specialties: Dermatology, Endocrinology, Infectology, Ophtalmology, Oncology, Hematology, Gynecology, Assisted Reproduction, Hepatology, Rheumatology, among others
• Distribution: More than 10,0000 requests per month
• Pharmacy of specialties: More than 5 thousand patients attended
• Patient Support: More than 500 thousand patients seen in 60 projects
d1000 is the brand of the Retail Division. It consists of the Drogasmil, Farmalife, Drogarias Tamoio and Drogaria Rosário chains and is the leader in Midwest Brazil, the 2nd largest chain in Rio de Janeiro in number of drugstores and the 6th largest pharmaceutical retail chain in Brazil. This division has tremendous potential for growth due to the strategies of maintaining the business characteristics of each of its brands, the geographical complementarity and positioning, the experience of its professionals and the consolidation of its identity as a set of brands.
• 52 Drogasmil brand stores
• 8 Farmalife stores
• 61 Tamoio stores
• 104 Rosário stores
• More than 2,400,000 consumers/month
• 4,077 employees
Profarma was founded in 1961 by Manoel Birmarcker. The Company started its operations in the state of Rio de Janeiro, in a small office in downturn Rio de Janeiro with easy access to the north and south regions of the city, where the main drugstore chains of the time were located.
The years that followed its founding were marked by a strong growth in the number of customers. In the 1970s, Profarma embarked on a process of diversifying its operations and expanding its network. Later it entered into partnerships and joint ventures with important pharmaceutical product manufacturers such as Bristol-Myers Squibb, Roche and Aché.
In the 1990s, it started expanding its operations to other regions of Brazil, accompanied by strict guidelines on sustainable growth in the long run. For this, the Company restructured all its areas.
In 1996, it launched operations in the state of Minas Gerais by opening a Distribution Center in Belo Horizonte. In 1997, it completed the automation of the picking process at the Distribution Center in the state of Rio de Janeiro.
In 1998, it opened a new Distribution Center in the city of Serra in Espírito Santo. The following year, it carried out a strategic acquisition of a wholesale distributor of pharmaceutical products in the state of São Paulo, KF Distribuidora, which had a Distribution Center in the city of São Paulo and another in the city of São Carlos in the interior region of the state.
After consolidating its operations in these five distribution centers, Profarma expanded its operations to other regions of Brazil. In 2001, it opened two distribution centers: one in the city of Curitiba, Paraná, in southern Brazil and the other in Brasília, Federal District in the Midwest region.
Due to its rapid expansion process, the Company renewed its technologies and completely upgraded its internal management processes. Important investments were made in information technology, such as the deployment of the SAP R/3 and BIS (Business Intelligence System) systems.
In 2002 and 2003, it started supplying pharmaceutical and hospital products to clinics and private hospitals in the states of Rio de Janeiro and São Paulo. In 2004, it started operating in Northeastern Brazil by opening a Distribution Center in the city of Salvador in Bahia.
In 2005, Profarma started distributing vaccines in the states of Rio de Janeiro, São Paulo, Minas Gerais and a few states in Northeastern Brazil through its subsidiary Promovac to diversify its product mix and obtain synergies from its business structure. The following year, its operations in Rio de Janeiro were transferred to a new Distribution Center with greater operating capacity.
Eager for major changes, in 2006 Profarma launched its IPO on the Novo Mercado segment of BM&FBovespa and became the first company in the segment to make this strategic move.
In 2007, Profarma forayed into new operating segments. In January, it opened a Distribution Center in the state of Pernambuco and in May in the state of Ceará. In July, it acquired the operating assets of Dimper in Rio Grande do Sul, taking its tally of distribution centers to 11. With this, it became a distributor with nationwide coverage.
In 2009, Profarma opened its 12th Distribution Center in the country: in Goiânia. The new Distribution Center was the second in the Midwest region, consolidating the Company’s presence in the region.
The Company’s Distribution Centers cover around 96% of the domestic consumers of pharmaceutical products.
With the focus on diversifying its product lines and channels in profitable segments with growth potential, Profarma acquired ArpMed in 2012. As a result, it included in its portfolio the sale of high-value specialty drugs and inaugurated its Specialties Division.
The year 2013 marked the start of a new strategic phase for the Company: the entry in retail pharmaceuticals segment with the acquisitions of the Drogasmil, Farmalife and Tamoio chains in Rio de Janeiro.
It thus consolidated its new positioning: Profarma Group – the most diversified player in the health sector in Brazil.
In 2014, it entered into a strategic association with AmerisourceBergen Corporation, one of the largest suppliers of pharmaceutical products and services in the world, which acquired 19.9% interest in Profarma by subscribing to new shares resulting from a capital increase. Together they set up Profarma Specialty, a joint venture with 50% interest held by each company, to expand operations in the Specialty Pharmaceuticals market. This association enabled the Profarma Group to continue its expansion process that started with the acquisition of Prodiet (2011) and ArpMed (2012). During this time, it launched N° 21, an exclusive hygiene and beauty brand.
To strengthen its Retail Division, in 2016 the company named its portfolio of brand leaders “d1000 varejo farma”. The same year, it carried out another capital increase, of about R$ 140 million, launched GOnutri, an exclusive vitamins and health supplements brand, and acquired 100% of Rosário, a chain of 150 drugstores operating for more than 40 years in Midwest Brazil. As a result, d1000 varejo farma doubled the size of its platform and became the leader in Midwest Brazil, the 2nd largest chain in number of stores in Rio de Janeiro and the 6th largest retail pharmaceutical chain in Brazil.